scholarly journals G.G. Levitsky. Kyphotic female pelvis. (Protocol of the meeting of the Obstetric and Gynecological Society in Kiev, book 7, 1894, p. 71)

2020 ◽  
Vol 9 (3) ◽  
pp. 269
Author(s):  
N. Kakushkin

Jewish woman, 22 years old. She gave birth once (forceps). After delivery, a vesicovaginal fistula was formed. Height is 141 cm. The limbs do not represent traces of a rickety process. Lordosis of the upper thoracic part of the spine and right-sided scoliosis of the lower thoracic part. Kyphosis lumbosacralis.

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
E Gialafos ◽  
E Tsougos ◽  
E Andreadou ◽  
D Tzanetakos ◽  
I Tzartos ◽  
...  

Abstract A wide spectrum of topics regarding Multiple Sclerosis (MS) have been thoroughly studied, like immunology, nature of demyelinating lesions (DL's), therapeutics, etc. However, little is known about the influence of MS DL's on the cardiovascular system and especially in the coronary vasculature although few reports mention coronary vasospasm due to autonomic nervous system (ANS) abnormalities. Aim of this study was the detection the presence of Neurogenic Stunned Myocardium (NSM) through perfusion test. Method We enrolled 50 asymptomatic fulfilling the criteria MS patients, aged 45±7 years old and disease in our study duration of 6±13 years with EDSS= 2,5. After echocardiography and clinical examination as primary screening, pharmacologic stress thallium 201 scintigraphy and/or coronary angiography were performed to identify the incidence of NSM. Clinical characteristics of MS, type of disease, treatments as well as localization of demyelinating plaques (DP) were noted. Results 13 patients (26%) had abnormal scintigraphy test although clinical profile was not indicative. Cardiac ultrasound showed that 2 patients from this group had a critical ejection fraction (around 50%). All positive patients that underwent for coronary angiogram were negative implying coronary artery spasm as a potential mechanism for the stress positive result. A common finding of all positive patients was the localization of DP which was in the lateral horn of the lower cervical part (C5–7) and upper thoracic part (Th1–4). No correlation seems to have the presence of CAD with disease duration, EDSS and treatment approaches. Discussion Our study shows a high incidence of NSM. This finding due to the location of the DP seems to correlate with ANS disturbance and might help to distinguish patients at higher risk.


2007 ◽  
Vol 177 (4S) ◽  
pp. 289-289
Author(s):  
Michael E. Woods ◽  
Jeff Bejma ◽  
Rodney Davis

e-Anatomy ◽  
2008 ◽  
Author(s):  
Antoine Micheau ◽  
Denis Hoa
Keyword(s):  

BMJ ◽  
1965 ◽  
Vol 2 (5455) ◽  
pp. 187-190 ◽  
Author(s):  
D. A. Birkett ◽  
G. H. Apthorp ◽  
D. A. Chamberlain ◽  
G. W. Hayward ◽  
E. G. Tuckwell

2021 ◽  
pp. 028418512110051
Author(s):  
Surasit Akkakrisee ◽  
Keerati Hongsakul

Background Endovascular treatment is a first-line treatment for upper thoracic central vein obstruction (CVO). Few studies using bare venous stents (BVS) in CVO have been conducted. Purpose To evaluate the treatment performance of upper thoracic central vein stenosis between BVS and conventional bare stent (CBS) in hemodialysis patients. Methods Hemodialysis patients with upper thoracic central vein obstruction who underwent endovascular treatment at the interventional unit of our institution from 1 January 2008 to 31 December 2018 were enrolled in the present study. CBS was used to treat central vein obstruction in 43 patients and BVS in 34 patients. We compared the primary patency rates and complications between the two stent types. P values < 0.05 were considered statistically significant. Results The patient demographic data between the CBS and BVS groups were similar. The characteristics of the lesions, procedures, and complications were not significantly different between the two groups ( P > 0.05). There were no statistically significant differences of primary patency rates at three and six months between the BVS and CBS groups (94.1% vs. 86.0% and 73.5% vs. 58.1%, respectively; P > 0.05). The primary patency rate at 12 months in the BVS group was significantly higher than that in the CBS group (61.8% vs. 32.6%; P = 0.008). Conclusion Endovascular treatment of central vein obstruction with BVS provided a higher primary patency rate at 12 months than CBS.


Sign in / Sign up

Export Citation Format

Share Document